JNJ-26489112 (JNJ26489112) is a broad-spectrum anticonvulsant that displays activity in rodents against audiogenic, electrically-induced, and chemically-induced seizures.

Thiopental sodium (DEA controlled substance) is administered intravenously for the production of complete anesthesia of short duration or for the induction of general anesthesia. It is also used for the control of convulsive states and for hypnosis. It has been used to reduce increased intracranial pressure.

Gossypetin 3′-O-glucoside is a gossypetin derivative. Gossypetin 3′-O-glucoside can be isolated from ethanolic extracts after Soxhlet extraction.